Pre-Existing Comorbidities Diminish the Likelihood of Seropositivity after SARS-CoV-2 Vaccination

Background: The impact of chronic health conditions (CHCs) on serostatus post-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination is unknown. Methods: We assessed serostatus post-SARS-CoV-2 vaccination among fully vaccinated adult residents of Jefferson County, Kentucky, USA, fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Amraotkar, Alok R., Bushau-Sprinkle, Adrienne M., Keith, Rachel J., Hamorsky, Krystal T., Palmer, Kenneth E., Gao, Hong, Rai, Shesh N., Bhatnagar, Aruni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9416221/
https://www.ncbi.nlm.nih.gov/pubmed/36016250
http://dx.doi.org/10.3390/vaccines10081363

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9416221/
https://www.ncbi.nlm.nih.gov/pubmed/36016250
http://dx.doi.org/10.3390/vaccines10081363

Ejemplares similares